On August 10, 2026, the U.S. Department of Justice (DOJ) announced that Veloxis Pharmaceuticals, Inc., a North Carolina-based drug manufacturer, agreed to pay over $46 million to resolve criminal and civil allegations that it paid healthcare professionals (HCPs) kickbacks in the form of lavish meals, alcohol, luxury trips, and payments to induce prescriptions of Envarsus XR, its kidney transplant immunosuppression drug.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Maura
Contact Maura, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack